Atara Biotherapeutics Market Sentiment

Atara Biotherapeutics Inc

ATRANASDAQ

$9.43

N/A

Últ. Act.: Oct 22, 4:05 PM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Comparar Informe de acciones

Atara Biotherapeutics Market Sentiment - Benzinga

Atara Biotherapeutics Market Sentiment

Market sentiment signals for Atara Biotherapeutics (ATRA): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 4.4% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

8 analysts

Options Flow (P/C)

—

Avg Consensus PT

$22

+137.8%

Highest Price Target

$58

+509.8%

Stifel

Lowest Price Target

$10

+6.0%

Freedom Broker

Short Interest

4.4%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
May 18, 2026	Freedom Broker	Ilya Zubkov—	+6.0%	$4 → $10	Upgrade	Sell→Hold
May 8, 2026	Canaccord Genuity	John Newman—	+37.9%	$6 → $13	Upgrade	Hold→Buy
Jan 21, 2026	Freedom Broker	Ilya Zubkov—	-57.6%	$16 → $4	Downgrade	Buy→Sell
Jan 13, 2026	Canaccord Genuity	John Newman—	-36.4%	$25 → $6	Downgrade	Buy→Hold
Dec 19, 2025	Canaccord Genuity	John Newman—	+165.1%	$17 → $25	Maintained	Buy
Jul 28, 2025	Freedom Broker	Ilya Zubkov—	+69.7%	$13 → $16	Maintained	Sell
May 23, 2025	Freedom Broker	Ilya Zubkov—	+37.9%	$11 → $13	Maintained	Sell
Mar 13, 2025	Freedom Broker	Ilya Zubkov—	+16.6%	$13 → $11	Maintained	Sell
Mar 11, 2025	Canaccord Genuity	John Newman—	+80.3%	$17 → $17	Maintained	Buy
Jan 28, 2025	HC Wainwright & Co.	Robert Burns—	—	—	Maintained	Neutral
Jan 22, 2025	HC Wainwright & Co.	Robert Burns—	—	—	Maintained	Neutral
Jan 17, 2025	Canaccord Genuity	John Newman—	+80.3%	$21 → $17	Maintained	Buy
Dec 20, 2024	Rodman & Renshaw	Tony Butler—	+165.1%	$25	Initiate	Buy
Nov 13, 2024	Canaccord Genuity	John Newman—	+122.7%	$13 → $21	Maintained	Buy
Aug 21, 2024	HC Wainwright & Co.	Robert Burns—	—	—	Maintained	Neutral
Aug 16, 2024	Mizuho	Salim Syed—	+90.9%	$25 → $18	Upgrade	Neutral→Outperform
Aug 13, 2024	Canaccord Genuity	John Newman—	+37.9%	$13 → $13	Maintained	Buy
Jul 17, 2024	Goldman Sachs	Tommie Reerink—	+16.6%	$13 → $11	Maintained	Sell
May 22, 2024	HC Wainwright & Co.	Robert Burns—	—	—	Maintained	Neutral
Apr 1, 2024	Stifel	Benjamin Burnett—	+509.8%	$120 → $58	Maintained	Hold
Nov 10, 2023	Goldman Sachs	Tommie Reerink—	+32.6%	$75 → $13	Maintained	Sell
Nov 9, 2023	Evercore ISI Group	Michael DiFiore—	—	—	Downgrade	Outperform→In-Line
Nov 9, 2023	HC Wainwright & Co.	Robert Burns—	—	—	Downgrade	Buy→Neutral
Nov 9, 2023	Mizuho	Salim Syed—	+165.1%	$775 → $25	Downgrade	Buy→Neutral